EMD Serono Appoints New Leaders - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

EMD Serono Appoints New Leaders



EMD Serono, a subsidiary of Merck KGaA, reported the appointments of Gary Zieziula as COO, Allene Diaz as senior vice-president of Managed Markets, Lisa Buffington as vice-president of US Communications, Alexander Kuta as vice-president and head of US Regulatory Affairs, and Michael Ruggiero as vice-president of US Government Affairs and Policy.

Zieziula is responsible for increasing the growth of the US organization by controlling the performance of EMD franchises.

Diaz is responsible for developing and executing Managed Markets marketing, sales, and contracting strategies for EMD Seronoproducts.

Buffington is responsible for executing all aspects of the company’s communications strategy, including external and employee communications, media relations, corporate reputation, product communications, community relations, as well as meetings and events.

Kuta is responsible for the strategic direction of EMD Serono’s regulatory efforts with the FDA, overseeing regulatory submissions in the US and strengthening interactions with the FDA.

Ruggiero is responsible for federal and state legislative, policy, political, and advocacy strategy and execution for EMD Serono’s business.

Source: EMD Serono

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here